DEADLINE EXTENDED: #WARFAccelerator and Nexus NeuroTech Ventures are teaming up this spring to launch a Neurotechnology Challenge Grant. This initiative aims to identify and support cutting-edge neurotechnologies developed at the University of Wisconsin-Madison. UW researchers with innovative projects that explore novel ways of diagnosing and treating neurological conditions, including but not limited to neurodegenerative, neuropsychiatric and neurodevelopmental disorders, are encouraged to apply for grants from the $100K fund by April 9. "We want to recognize and support UW-Madison researchers who are developing groundbreaking diagnostic and treatment methods for neurological conditions," says Erik Iverson, CEO of WARF. "Through our collaboration with Nexus NeuroTech Ventures, we aim to advance innovative solutions to these critical health challenges." #WisconsinInnovates (fb)

Why should I license a UW-Madison technology? Emily Bauer says, "Licensing a university technology means committing to an invention that could be 10 years ahead of its industry. It is a high-risk, high-reward opportunity for someone who is willing to invest in that and has faith in the technology and sees the potential that it has to make a difference in our society." #WARFFAQS To learn more about WARF, visit: https://warf.org (fb)